Graille Marc, Cladière Lionel, Durand Dominique, Lecointe François, Gadelle Danièle, Quevillon-Cheruel Sophie, Vachette Patrice, Forterre Patrick, van Tilbeurgh Herman
Institut de Biochimie et de Biophysique Moléculaire et Cellulaire, UMR8619 CNRS, Université Paris-Sud, IFR115, F-91405 Orsay, France.
Structure. 2008 Mar;16(3):360-70. doi: 10.1016/j.str.2007.12.020.
DNA topoisomerases resolve DNA topological problems created during transcription, replication, and recombination. These ubiquitous enzymes are essential for cell viability and are highly potent targets for the development of antibacterial and antitumoral drugs. Type II enzymes catalyze the transfer of a DNA duplex through another one in an ATP-dependent mechanism. Because of its small size and sensitivity to antitumoral drugs, the archaeal DNA topoisomerase VI, a type II enzyme, is an excellent model for gaining further understanding of the organization and mechanism of these enzymes. We present the crystal structure of intact DNA topoisomerase VI bound to radicicol, an inhibitor of human topo II, and compare it to the conformation of the apo-protein as determined by small-angle X-ray scattering in solution. This structure, combined with a wealth of experimental data gathered on these enzymes, allows us to propose a structural model for the two-gate DNA transfer mechanism.
DNA拓扑异构酶可解决转录、复制和重组过程中产生的DNA拓扑问题。这些普遍存在的酶对于细胞活力至关重要,并且是开发抗菌和抗肿瘤药物的高效靶点。II型酶通过依赖ATP的机制催化一条DNA双链穿过另一条DNA双链。由于其体积小且对抗肿瘤药物敏感,古细菌DNA拓扑异构酶VI(一种II型酶)是进一步了解这些酶的结构组织和作用机制的优秀模型。我们展示了与人类拓扑异构酶II抑制剂萝卜硫素结合的完整DNA拓扑异构酶VI的晶体结构,并将其与通过溶液中小角X射线散射测定的无配体蛋白构象进行比较。该结构与在这些酶上收集的大量实验数据相结合,使我们能够提出双门DNA转移机制的结构模型。